Services · GMP & GxP Consulting & QA Support · Roles we take on
GMP consultant: GMP expert for validation, audits and inspections
A GMP expert (SME expert) handles qualification, validation, computer system validation, GxP audits, inspection readiness and GMP documentation when in-house capacity or expertise is lacking. A&O's specialists work under GMP themselves, with our own manufacturing authorisation and GMP-certified laboratory in Itzehoe.
Key points at a glance
Reviewed by Dr. Olaf Mundszinger
Legal basis checked against the statutory text, as of October 2026
A GMP expert or SME expert takes on qualification and validation, computerised system validation, GxP audits, inspection readiness and GMP documentation.
You define both the scope and the form of support provided by our experienced GMP experts.
The responsibility remains with the manufacturer: The manufacturer reviews and approves plans, protocols, and documentation.
At A&O Pharma
We take on a defined project: qualification of equipment and rooms from DQ to PQ, process and cleaning validation, analytical method validation, computer system validation or a manufacturing transfer. Preparation for a GMP inspection and responses to audit findings can be commissioned in the same way.
We work within your quality system, for example on CAPA, deviations, change control, complaints, self-inspections and PQR, or help to set up a quality management system. This includes documents such as SOPs, the Site Master File and CMC documentation. If a position in quality assurance is vacant, our interim management is also an option.
We audit suppliers and service providers against GMP, GDP or GCP and support supplier qualification. The report gives you the basis for the assessment which, under Chapter 7, rests with you as the contract giver.
Process
You describe the occasion and timeframe, such as an upcoming inspection, a project or an audit. We get back to you within 1 to 2 days.
Scope, schedule and responsibilities are set out in a written contract, as required by Chapter 7 of the EU GMP Guide and Section 9 AMWHV.
Risk assessment, protocols, execution and reports. Review and approval stay with you.
You receive the report and documents. On request we accompany the inspection and the responses to findings.
What the law requires
Anyone who manufactures medicinal products commercially or professionally needs a manufacturing authorisation under section 13 of the German Medicinal Products Act (AMG). Section 3 of the German Medicinal Products and Active Substances Manufacturing Ordinance (AMWHV) refers to the EU GMP Guide. Wholesale distribution is governed by the EU Guidelines on Good Distribution Practice (GDP), which likewise require self-inspections, supplier qualification and validated systems. GMP, GDP and GCP are often grouped together under the term GxP.
Chapter 2 of the Guide requires consultants to have adequate education, training and experience for the subject they advise on. Under Chapter 7 and section 9 AMWHV, every outsourced activity needs a written contract.
A consultant may prepare protocols and documents, carry out qualification and validation, and conduct audits.
The manufacturer remains responsible for the pharmaceutical quality system and for reviewing and approving protocols supplied by a third party (Annex 15, point 2.6).
Batch certification remains with the Qualified Person under section 14 AMG.
The validation master plan defines the programme. Qualification runs from user requirements (URS) through DQ, factory acceptance testing (FAT) and site acceptance testing (SAT), IQ, OQ and PQ. Process and cleaning validation, validation of analytical test methods and change control follow. Scope and depth follow a documented risk assessment. Retrospective validation is no longer considered acceptable.
Under Annex 11, applications must be validated and IT infrastructure qualified. A risk assessment determines the extent of validation and of data integrity controls. Requirements include a system inventory, access controls, audit trails that are regularly reviewed and periodic evaluation of whether a system remains validated. Drafts of a revised Annex 11, a revised Chapter 4 and a new Annex 22 on artificial intelligence were open for consultation from July to October 2025.
Chapter 4 distinguishes instructions such as specifications and SOPs from records. In addition there is the Site Master File. Under Chapter 9, self-inspections must follow a pre-arranged programme and be recorded, and independent audits by external experts may also be useful. Under section 64 AMG, sites holding a manufacturing or import authorisation are generally inspected by the competent authority every two years.
Named individually
You know who is responsible for you before the contract starts and can reach that person directly. Cover comes from the same team.
Sascha Manthei
Business Development
Dr. Olaf Mundszinger
Founder and Managing Director
Leidy Fajardo
Risk Assessment and GMP Documentation
Dr. Emmanuel Bey
Development Analytics
Tatjana Pazer
Quality Management and Sterile Manufacturing
Dr. Klaus-Peter Kreth
Qualified Person (QP) under § 14 AMG
Alexander Trautmann
GMP Consulting and Training
Dr. Thomas Lutz
Qualified Person (QP) and Head of Production
Dr. Kai Huwig
Qualified Person (QP) and Head of Quality Control
Case studies
A research institution is setting up a GMP manufacturing facility for personalised peptide vaccines. We support it from regulatory classification through to qualification...
Read case Mid-sized company, marketing authorisation holderA marketing authorisation holder is planning to change manufacturer. We reviewed the CMC documentation, made recommendations on selecting a contract manufacturer and will...
Read case Sponsor of clinical trials, small biotech companyA new active substance from a non-EU country was to go into a phase 1 trial as an investigational medicinal product. We provided GMP oversight, project management, analyt...
Read caseWeighing it up
| External via A&O Pharma | Hire your own person | |
|---|---|---|
| Availability | At short notice for a project or phase, without a recruitment process. | Available only after recruitment and induction, then permanently on site. |
| Breadth of expertise | Access to several specialists, for example for qualification, computer system validation and audits. | One person covers what they know themselves. |
| Knowledge of your site | Needs time to become familiar with your equipment, processes and systems. | Knows the equipment, processes and contacts from day-to-day work. |
| Outside view | Looks at processes without the blind spots of routine. Chapter 9 names independent audits by external experts as useful. | Knows why processes are set up as they are, but more easily overlooks what has become routine. |
| Responsibility | Works to a written contract. The quality system and approvals remain with you. | Can hold roles in your quality system on a permanent basis. |
| Cost | Incurred only for the agreed service. With consistently high demand, a permanent position may be more economical. | Fixed staff costs, including in periods with little project work. |
Frequently asked questions
A GMP consultant helps manufacturers meet the requirements of Good Manufacturing Practice, for example in qualification, validation, audits, inspection readiness and documentation. The consultant works to a written contract, while responsibility for the quality system stays with the manufacturer.
GMP is Good Manufacturing Practice. GxP groups several good practices together, including GMP, Good Distribution Practice (GDP) for storage and transport and Good Clinical Practice (GCP) for clinical trials. GxP consulting therefore usually covers more than manufacturing.
Design qualification (DQ) shows that the design meets the user requirements and GMP, installation qualification (IQ) that the equipment is installed correctly. Operational qualification (OQ) shows that it performs as intended across its operating range, performance qualification (PQ) that it works effectively and reproducibly in the process.
Computer system validation is documented evidence that a computerised system reliably does its job. Annex 11 requires a risk assessment that also takes data integrity into account, access controls, regularly reviewed audit trails, data back-up and periodic evaluation. A&O validates computerised systems in its own laboratory in Itzehoe.
Yes. Under Annex 15, protocols supplied by a third party must be checked by the responsible personnel at the manufacturing site for suitability and compliance with internal procedures before approval.
A self-inspection or audit is the usual starting point, covering documentation, open deviations and CAPA, the status of qualification and validation, computerised systems and the control of outsourced activities. After the inspection come the responses to the findings with an action plan.
Under section 64 AMG, sites holding an authorisation under section 13 or section 72 AMG are generally inspected every two years. Unannounced inspections are provided for in particular where counterfeiting or serious defects are suspected.
Chapter 9 of the EU GMP Guide provides for self-inspections to be carried out independently and in detail by designated competent persons from the company. Independent audits by external experts may also be useful. Every self-inspection must be recorded with its observations and actions.
More roles we take on
Call us or write three lines. You will reach someone directly who can assess your subject professionally.
As a member of the Life Science Nord cluster, we benefit from a strong, innovative network and work with other experts in the industry on forward-looking developments.
As a registered supplier on Scientist.com, we can also be reached through this platform: companies registered there can send their project requests directly to us.
